About
Noel Buckley is a neurobiology academic at the University of Oxford and scientific co-founder of Scripta Therapeutics. In Scripta's 2025 launch materials, he is presented as the scientific co-founder collaborating on the company's initial focus in Alzheimer's disease and other neurodegenerative conditions. Public web results also include a separate Noel Buckley in the cycling industry, so this profile is scoped to the Oxford/Scripta individual.
Areas of interest
neurobiologyAlzheimer's diseaseneurodegenerationbiotechdrug discoveryAI-enabled drug discoverytranscription factorslongevity